Using a tailored chatbot to help African Americans quit smoking
Feasibility of Using a Culturally Tailored Conversational Agent for promoting smoking cessation treatment utilization in African Americans who use cigarettes
['FUNDING_OTHER'] · UNIVERSITY OF MINNESOTA · NIH-11160935
This study is testing a friendly chatbot designed to help African Americans who smoke by offering personalized support and resources to make quitting easier and more relatable.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MINNESOTA (nih funded) |
| Locations | 1 site (MINNEAPOLIS, UNITED STATES) |
| Trial ID | NIH-11160935 on ClinicalTrials.gov |
What this research studies
This research investigates the effectiveness of a culturally tailored conversational agent, or chatbot, designed to encourage African Americans who smoke to utilize smoking cessation treatments. The approach focuses on creating a supportive and relatable digital environment that addresses specific cultural factors influencing smoking behaviors. Participants will interact with the chatbot, which will provide personalized guidance and resources to aid in their quitting journey. The study aims to assess how well this technology can improve treatment uptake and support among this population.
Who could benefit from this research
Good fit: Ideal candidates for this research are African American adults who currently smoke cigarettes and are seeking to quit.
Not a fit: Patients who do not identify as African American or those who are not interested in quitting smoking may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance smoking cessation efforts among African Americans, leading to improved health outcomes.
How similar studies have performed: Previous research has shown that culturally tailored interventions can be effective in promoting health behavior changes in diverse populations, suggesting potential success for this approach.
Where this research is happening
MINNEAPOLIS, UNITED STATES
- UNIVERSITY OF MINNESOTA — MINNEAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ALLEN, MICHELE L — UNIVERSITY OF MINNESOTA
- Study coordinator: ALLEN, MICHELE L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.